S

Setshaba Research Centre | Pharmacy Department

Research site

(Unclaimed)

Location

2088 Block H, Pretoria, Gauteng, South Africa

Site insights

Top conditions

Top treatments

PA-824

isoniazid

Truvada

Ethambutol

Moxifloxacin

Nimenrix

Pyrazinamide

rifampicin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 9 total trials

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

The purpose of this study is to assess the safety and immunogenicity of mRNA-1365, an mRNA vaccine targeting respiratory syncytial virus (RSV) and hu...

Enrolling

Human Metapneumovirus

Respiratory Syncytial Virus

Biological: Placebo

Biological: mRNA-1345

Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study. (Sisonke Boost)

To evaluate the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine plus a homologous boostwith Ad26.COV2.S COVID-19 vaccine among Sisonke...

Enrolling

SARS CoV 2 Infection

Biological: Booster vaccine

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting

COVID-19

Other: Placebo

Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Open Label Crossover Vaccination period)